Jennifer Flexman presented "Improving Access to Dementia Care though AI-Powered Cognitive Rehabilitation Therapy" at the Technology And Dementia Preconference during Session 5: Data Blitz.
John Ralston presented on the NEURVESTA device mentioning the MassAITC pilot project work on January 14, 2025 as an featured AI startup at the AI Healthcare Event in association with the JP Morgan Healthcare Conference. Source: Event Post on MIT Club of Northern California Website
Dr. Gang Wang gave a virtual talk at Columbia University (mobile computing seminar) which highlighted this project and the prototype design. Title: Defending against Spoofing Attacks in Mobile Networks and Applications Presenter: Gang Wang (PI)
Dr. Inbal Billie Nahum-Shani (PI) presented work from this pilot project during a talk titled "Adaptive interventions and JITAIs as decision policies: What and why?" as part of Session 1 - Digital adaptive interventions: decision-focused evidence production held on October 16, 2024. Source: NIA Event Page
Title: Automated Physical Performance Battery as a Digital Marker for Alzheimer's Disease and Mild Cognitive ImpairmentPresenter: Ehsan Adeli (PI) Abstract: Historically, screening for incidence of AD-related MCI or conversion from MCI to AD dementia has relied on cognitive, activities of daily living, and brain imaging measures. Limitations of this diagnostic approach include dependency on education and language, time-consuming and costly measures, and long-term monitoring. Emerging studies suggest that non-tremor motor dysfunction in dementias is known to be highly associated with AD biomarkers, with signs of cognitive decline visible in gait and hand movement at various stages of the illness. With the evidence that gait and physical disturbances are early predictors of cognitive impairment and that their trajectories could readily be tracked, we utilize recent advances in computer vision (CV) to quantify mobility in a data-driven…
Abstract: There is growing recognition of the importance of changes in behavior as an early clinical marker of the onset of Alzheimer’s disease. Behavior symptoms may precede the onset of cognitive symptoms by as many as three years. However, these symptoms are often confused for primary psychiatric pathology and there is an urgent need for markers that can help quantify behaviors with the eventual goal of helping distinguish behavior changes related to psychiatric pathology from behavior changes related to the onset of dementia. This talk will summarize the state of knowledge on mild behavioral impairment, and present data from three studies demonstrating how a range of sensor-derived biomarkers can quantify subtle changes in behavior with precision. The talk will include case presentations around detection of apathy, agitation, pacing. It will also demonstrate how these markers…
Dr. Jennifer Myers presented "An Equitable ML-based Music Intervention for At-risk Older Adults," at the Alzheimer’s Association International Conference (Preconference) in Philadelphia, PA. The presentation was part of the Introduction To The Artificial Intelligence And Technology Collaboratories (AITC) For Aging Research Program Pilot Project Showcase